10x genomics CEO Serge Saxonov contributes $1.95M in shares By Investing.com
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- TXG 10x Genomics-30.3% 30d
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR+0.6% 30d
Industrial Select Sector SPDR holds the industrials sector that 10x Genomics belongs to, so it often moves with news about it.
- A Agilent Technologies+1.1% 30d
Agilent Technologies is a peer of 10x Genomics in laboratory analytical instruments; rivals often move on the same news.
- WAT Waters+2.2% 11d
Waters is a peer of 10x Genomics in laboratory analytical instruments; rivals often move on the same news.
- ILMN Illumina-23.4% 30d
Illumina is a peer of 10x Genomics in laboratory analytical instruments; rivals often move on the same news.
- RVTY Revvity-4.0% 8d
Revvity is a peer of 10x Genomics in laboratory analytical instruments; rivals often move on the same news.
- AVTR Avantor-6.3% 12d
Avantor is a peer of 10x Genomics in laboratory analytical instruments; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| TXG | +11.95% | +6.70% | base | after close | after close | after close | after close |
| XLI | +0.05% | +1.29% | base | after close | after close | after close | after close |
| A | +3.60% | +1.73% | base | after close | after close | after close | after close |
| WAT | +3.64% | +2.24% | base | after close | after close | after close | after close |
| ILMN | +6.66% | +2.78% | base | after close | after close | after close | after close |
| RVTY | +4.01% | +2.38% | base | after close | after close | after close | after close |
| AVTR | +2.32% | +1.22% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
10x genomics CEO Serge Saxonov contributes $1.95M in shares By Investing.com Investing.com Nigeria
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| A | three days earlier | +1.73% | final price |
| A | five days earlier | +3.60% | final price |
| AVTR | three days earlier | +1.22% | final price |
| AVTR | five days earlier | +2.32% | final price |
| ILMN | three days earlier | +2.78% | final price |
| ILMN | five days earlier | +6.66% | final price |
| RVTY | three days earlier | +2.38% | final price |
| RVTY | five days earlier | +4.01% | final price |
| TXG | three days earlier | +6.70% | final price |
| TXG | five days earlier | +11.95% | final price |
| WAT | three days earlier | +2.24% | final price |
| WAT | five days earlier | +3.64% | final price |
| XLI | three days earlier | +1.29% | final price |
| XLI | five days earlier | +0.05% | final price |
Congressional trades in the stocks in this story
- Rep. Gilbert Cisneros sold Illumina (ILMN), worth $1,001 - $15,000 on 27 Oct 2026. That is 18 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $1,001 - $15,000 on 27 Oct 2026. That is 18 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $15,001 - $50,000 on 9 Sep 2026. That is 66 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $1,001 - $15,000 on 4 Sep 2026. That is 71 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“10x genomics CEO Serge Saxonov contributes $1.95M in shares By Investing.com” scores 12 out of 100. The score uses 1 sources.